MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Carcinoma in situ of unspecified bronchus and lung (D02.20)

HealthDay 16 November at 04.33 PM

Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC

For patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), osimertinib with chemotherapy leads to significantly longer progression-free survival (PFS) compared with osimertinib alone, according to a study published online Nov. 8 in the New England Journal of Medicine.David Planchard, M.D., Ph.D., from Institu